Compare Liquidia Corporation Common Stock (LQDA) vs MPLX LP (MPLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs MPLX LP — how do they compare? Liquidia Corporation Common Stock trades at $33.9 (market cap $3.04B), while MPLX LP trades at $57.5 (market cap $58.26B). The key difference: MPLX LP is far larger — about 19.2× Liquidia Corporation Common Stock's market cap, and MPLX LP pays a 7.49% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals.
| LQDA | MPLX | |
|---|---|---|
Market Cap | $3.04B | $58.26B |
Volume | 21,111,778 | 2,089,896 |
Sector | Health | Energy |
52-Week High | $91.03 | $60.51 |
52-Week Low | $22.02 | $48.53 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $2.94B | $83.36B |
Dividend Yield | — | 7.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MPLX trades at $56.91 with minimal daily movement (+0.14%). Technical indicators show a bearish trend while fundamentals remain strong with a 40.45% net income margin and 33.95% ROE. The company maintains robust cash flow generation of $5.91B from operations in 2025, supporting its $1.08 dividend. Recent earnings showed mixed results with one beat and two misses in the last three quarters.
Wall Street maintains a bullish outlook with 19 buy ratings and a $63.80 consensus price target, representing 12% upside potential. Key risks include energy market volatility and execution challenges, but MPLX's fee-based revenue model provides stability. The stock offers value at a 12.36 P/E ratio with dividend income appeal.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →
